Rindopepimut vaccine and bevacizumab combination therapy: improving survival rates in relapsed glioblastoma patients? [electronic resource]
- Immunotherapy 2015
- 603-6 p. digital
Publication Type: Journal Article; Review
1750-7448
10.2217/imt.15.39 doi
Bevacizumab--therapeutic use Cancer Vaccines--therapeutic use Glioblastoma--therapy Humans Portraits as Topic Recurrence Vaccines, Subunit--therapeutic use